Archive | Biotech RSS feed for this section

3 Ways to Profit in the Market’s Most Underrated Sector

After rallying 8% just in February, the market’s worst performing sector last year looks like it could become the market’s best performing sector this year. Bret Jensen shares three ways he’s positioning his portfolio and his investments to make money from the massive turnaround.  The amount of questions I am getting about the biotech sector […]

Read more

3 Themes to Watch in the Market’s Top Turnaround Sector

Finding the best returns of the next twelve months usually starts with searching out the stocks and sectors that did the worst in the last twelve. Here’s what to watch in the market’s best bet for big returns in 2017. After underperforming the overall market substantially for some 18 months, the biotech sector appears to […]

Read more

3 Attractive Growth Stocks with Near-Term Catalysts

The market is off to a much stronger start this year than the bloodbath equities were greeted with to begin 2016. Biotech, after a dismal 18 months of underperformance is no exception. Sentiment on this beaten down part of the market started to improve immediately after the unexpected election result in November. The specter of […]

Read more

5 Growth Stocks with Major Profit Trends to Bank On

If you’re looking for the next big driver of profit growth in the markets, consider investing in these five stocks that Bret Jensen has identified today. All five have catalysts for growth happening right now, so don’t wait and see which stocks Bret’s recommending today. Snapping up this fast-growing software company might be just the […]

Read more

3 Off-the-Radar Biotech Picks with Upside Potential

Bret Jensen shares three small cap biotech stocks that have attractive risk to reward profiles and will fit nicely into an aggressive investor’s portfolio. The biotech sector, after being shellacked in 2016, is off to a much stronger start so far in 2017. This area of the market has posted solid gains in January to […]

Read more

3 American-Based Businesses that Trump Loves

These three companies employ tens of thousands of Americans and will never be shipping jobs or factories overseas, giving them an A+ rating from Trump. With the President-elect’s support behind them, these stocks should do well. Trump has started fulfilling his campaign promise of ‘strong arming’ companies to stop moving jobs out of the country […]

Read more

3 Reasons Why this Biotech Rally is the Real Deal

After dropping some 20% in 2016, the biotech sector could be set for the rally of a lifetime in 2017 and make current investors a fortune in the process. See why Bret Jensen thinks this rally is for real in today’s article.  The biotech sector was one of the poorest performers in the market in […]

Read more

3 Stocks under $10 with Breakout Potential

After executing perfectly on their business plans in 2016, these three stocks look set to reap the profits in 2017. With buyout potential and higher share prices expected in the New Year, adding these three stocks to your portfolio today looks like a smart move.  It is hard to believe 2016 has already come and […]

Read more

The 3 Stocks that Will Go from Worst to First in 2017

Take advantage of the stock market phenomenon where the worst performers of the last 12 months tend to become the best performers in the next. Bret Jensen searched through the 25 biggest laggards in the S&P 500 and found three stocks to buy for share price gains.  The NFL regular season has now drawn to […]

Read more

3 Best Buy Healthcare Stocks Too Cheap by Half

Easily taking the prize of the worst performing sector in 2016, healthcare stocks look set to turnaround in 2017 with a more pro-industry administration in office. With that in mind, check out these three growth stocks on sale today.  From political outlash to Hillary Clinton’s tweet storms on drug pricing, the healthcare industry has had […]

Read more